NCT01354483View on ClinicalTrials.gov

Umbilical Cord Blood Mononuclear Cell Transplant to Treat Chronic Spinal Cord Injury

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2013

Study Completion Date

December 31, 2013

Conditions
Spinal Cord Injuries
Interventions
BIOLOGICAL

Umbilical Cord Blood Mononuclear Cell

BIOLOGICAL

Methylprednisolone

30mg/kg i.v. methylprednisolone

DRUG

Lithium Carbonate Tablet

6 weeks

Trial Locations (1)

650032

Treating Center of Spinal Cord Injury, Chengdu Army Kunming General Hospital, Kunming

All Listed Sponsors
collaborator

Chengdu PLA General Hospital

OTHER

lead

China Spinal Cord Injury Network

NETWORK

NCT01354483 - Umbilical Cord Blood Mononuclear Cell Transplant to Treat Chronic Spinal Cord Injury | Biotech Hunter | Biotech Hunter